SCHEMBL6377992

SCHEMBL6377992

COCCOCCOC.C[NH+](C)c1ccccc1.Fc1c(F)c(F)c([B-](c2c(F)c(F)c(F)c(F)c2F)(c2c(F)c(F)c(F)c(F)c2F)c2c(F)c(F)c(F)c(F)c2F)c(F)c1F

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6378920 0.95 CA2 (0.37) CA2
Di(Hydroxyethyl)Ether SCHEMBL8500097 0.86 KCNH3 (0.31)
Ether SCHEMBL6654560 0.83 HPGD (0.30)
SCHEMBL30973629 0.82
SCHEMBL6379550 0.79 RECQL (0.32)
SCHEMBL6376624 0.79 RECQL (0.32)
SCHEMBL6377929 0.79 RECQL (0.32)
SCHEMBL29907880 0.78
SCHEMBL29497620 0.78
SCHEMBL394834 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1400524-B1 Tetrakis(fluoroaryl) borate/ether complexes and process for preparing the same NIPPON CATALYTIC CHEM IND (JP) 2005-11-30 EP disclosed
EP-1400525-B1 Process for preparing tetrakis (fluoroaryl) borate derivatives NIPPON CATALYTIC CHEM IND (JP) 2005-11-30 EP disclosed
EP-1400525-A1 Process for preparing tetrakis (fluoroaryl) borate derivatives Nippon Shokubai Co., Ltd. (JP) 2004-03-24 EP disclosed
EP-1400524-A1 Tetrakis(fluoroaryl) borate/ether complexes and process for preparing the same Nippon Shokubai Co., Ltd. (JP) 2004-03-24 EP disclosed
US-6624329-B2 Formed by reacting with acid or ether; by-product inhibition; chemical intermediates NIPPON SHOKUBAI CO., LTD. (JP) 2003-09-23 US disclosed
US-20020107419-A1 Purifying process of tetrakis (fluoroaryl) borate.magnesium halide, tetrakis (fluoroaryl) borate.ether complex and producing process of the same, and producing process of tetrakis (fluoroaryl) borate derivative NIPPON SHOKUBAI CO., LTD. 2002-08-08 US disclosed
US-6380435-B2 CHEMICAL INTERMEDIATE FOR POLYMERIZATION CATALYST NIPPON SHOKUBAI CO., LTD. (JP) 2002-04-30 US disclosed
US-20010014739-A1 Purifying process of tetrakis (fluoroaryl) borate.magnesium halide, tetrakis (fluoroaryl) borate.ether complex and producing process of the same, and producing process of tetrakis (fluoroaryl) borate derivative NIPPON SHOKUBAI CO., LTD. 2001-08-16 US disclosed
US-6215025-B1 Method for purifying tetrakis (fluoroaryl) borate/magnesium halide, tetrakis (fluoroaryl) borate/ether complex and process for preparing the same, and process for preparing tetrakis (fluoroaryl) borate derivative NIPPON SHOKUBAI CO., LTD. (JP) 2001-04-10 US disclosed
EP-0913400-A1 METHOD FOR PURIFYING TETRAKIS(FLUOROARYL) BORATE/MAGNESIUM HALIDE, TETRAKIS(FLUOROARYL) BORATE/ETHER COMPLEX AND PROCESS FOR PREPARING THE SAME, AND PROCESS FOR PREPARING TETRAKIS(FLUOROARYL) BORATE DERIVATIVE Nippon Shokubai Co., Ltd. (JP) 1999-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010014739-A1 Purifying process of tetrakis (fluoroaryl) borate.magnesium halide, tetrakis (fluoroaryl) borate.ether complex and producing process of the same, and producing process of tetrakis (fluoroaryl) borate derivative BMX, BRIX1, CYP4X1 CA2 590/4885
US-20020107419-A1 Purifying process of tetrakis (fluoroaryl) borate.magnesium halide, tetrakis (fluoroaryl) borate.ether complex and producing process of the same, and producing process of tetrakis (fluoroaryl) borate derivative BMX, BRIX1, MLX CA2 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.